Hologic Inc

The Florida Department of Health (the Department) is seeking to procure proprietary Aptima HIV-1 Quant Dx testing reagents for use in the Department's Bureau of Public Health Laboratories (BPHL) HIV testing algorithm. The Department is requesting authorization to purchase these reagents as a single source item from Hologic, Inc., the sole distributor of the Aptima HIV-1 Quant Dx assay. This assay is the only dual claim assay intended to be used as an aid in the diagnosis of HIV-1 infection. The contract term is 3 years, and the estimated dollar amount of the purchase is $712,800.00. The justification for the single source acquisition is that it is in the best interest of the state to maintain continuity by using these specialized kits and reagents with the Department's existing HIV testing algorithm. The procurement is governed by the Florida Administrative Code, Chapter 60A-1.045.

This opportunity is limited to Hologic, Inc. as the sole provider of the required Aptima HIV-1 Quant Dx testing reagents. There are no set-aside designations or restrictions on the types of organizations that can respond. The Department has not indicated any incumbent vendors or current contractors, and there is no information provided about any existing infrastructure or technology that requires integration. The budget for this contract is $712,800.00.